Breast biopsy is a preliminary test that detects the area of an abnormal tissue growth or diagnoses the presence of cancerous cells. Defects or abnormalities are detected in the cell with the help of devices, such as vacuum-assisted biopsy, core needle biopsy, and fine needle biopsy. Moreover, assist the surgeons or radiologist performing the biopsy and using specialized imaging equipment, such as ultrasound, mammography-guided stereotactic biopsy that employs x-ray, and others.
The breast biopsy market was valued at $976.7 million in 2016, and is projected to reach at $1,420 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. This is attributed to the growth in incidence of breast cancer, increase in awareness regarding breast cancer screening programs, rise in demand for minimally invasive surgeries for breast biopsy, and new reimbursement guidelines for biopsy procedures in the U.S.. However, various regulatory issues and risks of infection in breast biopsy procedures hamper the market growth. The developing countries are expected to offer abundant growth opportunities to the breast biopsy market.
The global breast biopsy market is segmented on the basis of product, image-guided technology, end user, and geography. On the basis of product, it is classified into vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB). Based on image guided technology, it is divided into MRI-guided biopsy, ultrasound guided biopsy, mammography guided stereotactic biopsy, CT-guided biopsy, and others. On the basis of end user, it is bifurcated into diagnostic centers and hospitals. Geographically, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.
KEY BENEFITS
This report provides an extensive analysis of the current & emerging market trends and dynamics in the global breast biopsy market.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- and country-wise market conditions are analyzed in the report.
Breast Biopsy Market Key Segments:
By Product
Vacuum Assisted Biopsy (VAB)
Core Needle Biopsy (CNB)
Fine Needle Aspiration Biopsy (FNAB)
By Image Guided Technology
MRI-Guided Biopsy
Ultrasound Guided Biopsy
Mammography Guided Stereotactic Biopsy
CT-Guided Biopsy
Others
By End User
Diagnostic Centers
Hospitals
By Geography
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Singapore
Philippines
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Israel
Saudi Arabia
South Africa
Rest of LAMEA
KEY PLAYERS
Hologic Inc.
Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.)
C. R. Bard, Inc.
Becton and Dickinson Company
Argon Medical Devices
Cook Medical Incorporated
Encapsule medical Devices LLC.
Ethicon Endo Surgery (Johnson & Johnson)
Intact Medical Corporation
Galini SRL
OTHER PLAYERS
Zenalux Biomedical, Inc.
F. Hoffmann-La Roche Ltd.
OncoCyte Corporation
Laboratory Corporation of America Holdings (Labcorp)
Scion Medical Technologies
Planmed Oy
Aurora Imaging Technology Inc.
Carestream Health
Cardinal Health
PerkinElmer
